文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

急性肾损伤诊断标准对肾脏替代治疗启动时机与死亡率关系的差异效应:IDEAL-ICU试验亚组分析

Differential effect on mortality of the timing of initiation of renal replacement therapy according to the criteria used to diagnose acute kidney injury: an IDEAL-ICU substudy.
PubMed 文献 · Crit Care · 2023-08-17
一句话结论IDEAL-ICU亚组分析显示,仅以肌酐升高诊断AKI的脓毒性休克患者,早期启动肾脏替代治疗与90天死亡率显著增加相关(58% vs 42%,p=0.028)。

该研究为IDEAL-ICU随机试验的亚组分析,纳入488例早期脓毒性休克合并AKI患者,按AKI诊断标准分为三组:仅肌酐升高组(205例,42%)、仅尿量减少组(174例,35%)、肌酐升高联合尿量减少组(100例,20%)。主要终点为90天全因死亡。结果显示,RRT启动策略(早期 vs 延迟)对90天死亡率的影响在不同诊断标准组间存在显著异质性(校正交互作用p=0.021)。仅肌酐升高组中,早期RRT与死亡率显著增加相关(58% vs 42%,p=0.028);仅尿量减少组中,延迟RRT与死亡率非显著绝对增加10%相关(57% vs 67%,p=0.18);联合组无显著差异(58% vs 55%,p=0.79)。次要终点无显著差异。

要点

  • 仅以肌酐升高诊断AKI的脓毒性休克患者,早期启动RRT与90天死亡率显著增加相关(58% vs 42%,p=0.028)。
  • 仅以尿量减少诊断AKI的患者,延迟启动RRT与90天死亡率非显著绝对增加10%相关(57% vs 67%,p=0.18)。
  • 肌酐升高联合尿量减少组中,早期与延迟RRT的90天死亡率无显著差异(58% vs 55%,p=0.79)。
  • RRT启动策略对90天死亡率的影响在不同AKI诊断标准组间存在显著异质性(校正交互作用p=0.021)。
  • 次要终点(无RRT天数、RRT依赖、出院时肾功能)在各组间均无显著差异。

适用人群与场景

  • IDEAL-ICU随机试验纳入的早期脓毒性休克合并急性肾损伤患者,共488例。
  • 按AKI诊断标准分为三组:仅肌酐升高组205例(42%)、仅尿量减少组174例(35%)、肌酐升高联合尿量减少组100例(20%)。

诊断标准与关键阈值

  • AKI诊断标准分组:仅肌酐升高(组1)、仅尿量减少(组2)、肌酐升高联合尿量减少(组3)。

处置流程与药物剂量

  • 肾脏替代治疗启动策略分为早期与延迟两组,具体启动时机及方案未在摘要中描述。

研究设计与关键结果

  • 研究类型:IDEAL-ICU随机试验的亚组分析。
  • 样本量:488例早期脓毒性休克合并AKI患者。
  • 主要终点:90天全因死亡。RRT启动策略与AKI诊断标准组间交互作用显著(校正交互作用p=0.021)。
  • 仅肌酐升高组:早期RRT vs 延迟RRT的90天死亡率分别为58% vs 42%(p=0.028)。
  • 仅尿量减少组:早期RRT vs 延迟RRT的90天死亡率分别为57% vs 67%(p=0.18)。
  • 肌酐升高联合尿量减少组:早期RRT vs 延迟RRT的90天死亡率分别为58% vs 55%(p=0.79)。
  • 次要终点(无RRT天数、RRT依赖、出院时肾功能)无显著差异。

证据类型、等级与局限

  • 证据类型:随机对照试验IDEAL-ICU的亚组分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,RRT启动时机对结局的影响因AKI诊断标准而异;对于仅肌酐升高的患者,早期RRT与死亡率显著增加相关;对于仅尿量减少的患者,延迟RRT与死亡率非显著绝对增加10%相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: This substudy of the randomized IDEAL-ICU trial assessed whether the timing of renal replacement therapy (RRT) initiation has a differential effect on 90-day mortality, according to the criteria used to diagnose acute kidney injury (AKI), in patients with early-stage septic shock.

METHODS: Three groups were considered according to the criterion defining AKI: creatinine elevation only (group 1), reduced urinary output only (group 2), creatinine elevation plus reduced urinary output (group 3). Primary outcome was 90-day all-cause death. Secondary endpoints were RRT-free days, RRT dependence and renal function at discharge. We assessed the interaction between RRT strategy (early vs. delayed) and group, and the association between RRT strategy and mortality in each group by logistic regression.

RESULTS: Of 488 patients enrolled, 205 (42%) patients were in group 1, 174 (35%) in group 2, and 100 (20%) in group 3. The effect of RRT initiation strategy on 90-day mortality across groups showed significant heterogeneity (adjusted interaction p = 0.021). Mortality was 58% vs. 42% for early vs. late RRT initiation, respectively, in group 1 (p = 0.028); 57% vs. 67%, respectively, in group 2 (p = 0.18); and 58% vs. 55%, respectively, in group 3 (p = 0.79). There was no significant difference in secondary outcomes.

CONCLUSION: The timing of RRT initiation has a differential impact on outcome according to AKI diagnostic criteria. In patients with elevated creatinine only, early RRT initiation was associated with significantly increased mortality. In patients with reduced urine output only, late RRT initiation was associated with a nonsignificant, 10% absolute increase in mortality.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Barbar SD, Bourredjem A, Trusson R, et al. Differential effect on mortality of the timing of initiation of renal replacement therapy according to the criteria used to diagnose acute kidney injury: an IDEAL-ICU substudy. Crit Care. 2023. PMID: 37592355. doi:10.1186/s13054-023-04602-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。